Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Techne (TECH) Deferred Taxes (2016 - 2025)

Bio-Techne (TECH) has 17 years of Deferred Taxes data on record, last reported at -$72000.0 in Q4 2025.

  • For Q4 2025, Deferred Taxes rose 99.11% year-over-year to -$72000.0; the TTM value through Dec 2025 reached -$32.5 million, down 6.34%, while the annual FY2025 figure was -$51.1 million, 29.56% down from the prior year.
  • Deferred Taxes reached -$72000.0 in Q4 2025 per TECH's latest filing, down from $5.3 million in the prior quarter.
  • Across five years, Deferred Taxes topped out at $5.4 million in Q3 2021 and bottomed at -$32.3 million in Q2 2025.
  • Average Deferred Taxes over 5 years is -$6.8 million, with a median of -$5.8 million recorded in 2021.
  • Peak YoY movement for Deferred Taxes: surged 1296.24% in 2021, then tumbled 2586.41% in 2023.
  • A 5-year view of Deferred Taxes shows it stood at $1.8 million in 2021, then plummeted by 187.51% to -$1.6 million in 2022, then plummeted by 571.03% to -$10.7 million in 2023, then increased by 24.68% to -$8.1 million in 2024, then soared by 99.11% to -$72000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Deferred Taxes were -$72000.0 in Q4 2025, $5.3 million in Q3 2025, and -$32.3 million in Q2 2025.